• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Editorial: Steatotic Liver Diseases Emerge as Rapidly Growing Drivers of Primary Liver Cancer in the United States.社论：脂肪性肝病在美国迅速成为原发性肝癌的主要驱动因素。
Aliment Pharmacol Ther. 2025 Mar;61(6):1057-1058. doi: 10.1111/apt.18508. Epub 2025 Jan 23.
2
Editorial: Steatotic Liver Diseases Emerge as Rapidly Growing Drivers of Primary Liver Cancer in the United States-Author's Reply.社论：脂肪性肝病成为美国原发性肝癌快速增长的驱动因素——作者回应。
Aliment Pharmacol Ther. 2025 Mar;61(6):1059-1060. doi: 10.1111/apt.18511. Epub 2025 Jan 23.
3
Vibration-controlled transient elastography in shaping the epidemiology and management of steatotic liver disease: Editorial on "Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023".振动控制瞬时弹性成像在脂肪性肝病的流行病学及管理中的作用：关于《2017 - 2023年美国成年人脂肪性肝病和肝纤维化的当前负担》的社论
Clin Mol Hepatol. 2025 Apr;31(2):620-624. doi: 10.3350/cmh.2024.1131. Epub 2024 Dec 26.
4
The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on "Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023".2019冠状病毒病大流行之前及期间脂肪性肝病的负担：致关于“2017 - 2023年美国成年人脂肪性肝病和肝纤维化的当前负担”的社论的信函
Clin Mol Hepatol. 2025 Apr;31(2):e183-e185. doi: 10.3350/cmh.2025.0152. Epub 2025 Feb 17.
5
Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on "Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023".应对脂肪性肝病负担：瞬时弹性成像的作用：致关于“2017 - 2023年美国成年人脂肪性肝病和纤维化的当前负担”的社论的信
Clin Mol Hepatol. 2025 Apr;31(2):e180-e182. doi: 10.3350/cmh.2025.0125. Epub 2025 Feb 13.
6
Alcohol-Related Liver Disease, Followed by Metabolic Dysfunction-Associated Steatotic Liver Disease, Emerges as the Fastest-Growing Aetiologies for Primary Liver Cancer in the United States.酒精性肝病，其次是代谢功能障碍相关脂肪性肝病，成为美国原发性肝癌增长最快的病因。
Aliment Pharmacol Ther. 2025 Mar;61(6):959-970. doi: 10.1111/apt.18473. Epub 2025 Jan 5.
7
Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States.社论：美国HIV感染者脂肪性肝病的最新流行病学情况
Aliment Pharmacol Ther. 2024 Mar;59(6):789-790. doi: 10.1111/apt.17871.
8
Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States-Authors' reply.社论：美国HIV感染者脂肪性肝病的最新流行病学——作者回复
Aliment Pharmacol Ther. 2024 Mar;59(6):791. doi: 10.1111/apt.17886.
9
Loss of L-selectin-guided CD8 , but not CD4 , cells protects against ischemia reperfusion injury in a steatotic liver.L-选择素引导的CD8⁺细胞而非CD4⁺细胞的缺失可保护脂肪变性肝脏免受缺血再灌注损伤。
Hepatology. 2017 Oct;66(4):1258-1274. doi: 10.1002/hep.29276. Epub 2017 Sep 4.
10
Minimizing Risks of Liver Transplantation With Steatotic Donor Livers by Preferred Recipient Matching.通过优选受者匹配，降低脂肪变性供肝肝移植的风险。
Transplantation. 2020 Aug;104(8):1604-1611. doi: 10.1097/TP.0000000000003052.

本文引用的文献

1
Alcohol-Related Liver Disease, Followed by Metabolic Dysfunction-Associated Steatotic Liver Disease, Emerges as the Fastest-Growing Aetiologies for Primary Liver Cancer in the United States.酒精性肝病，其次是代谢功能障碍相关脂肪性肝病，成为美国原发性肝癌增长最快的病因。
Aliment Pharmacol Ther. 2025 Mar;61(6):959-970. doi: 10.1111/apt.18473. Epub 2025 Jan 5.
2
Changing Epidemiology of Hepatocellular Carcinoma Within the United States and Worldwide.美国及全球肝细胞癌流行病学的变化
Surg Oncol Clin N Am. 2024 Jan;33(1):1-12. doi: 10.1016/j.soc.2023.06.004. Epub 2023 Aug 31.
3
Review article: current and emerging therapies for the management of cirrhosis and its complications.综述文章：肝硬化及其并发症管理的当前及新兴疗法
Aliment Pharmacol Ther. 2022 May;55(9):1099-1115. doi: 10.1111/apt.16831. Epub 2022 Mar 2.
4
MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective.将 MAFLD 视为全球丙型肝炎消除工作的一部分：国际视角。
Aliment Pharmacol Ther. 2021 May;53(10):1080-1089. doi: 10.1111/apt.16346. Epub 2021 Mar 22.
5
Epidemiology of Hepatocellular Carcinoma.肝细胞癌的流行病学
Hepatology. 2021 Jan;73 Suppl 1(Suppl 1):4-13. doi: 10.1002/hep.31288. Epub 2020 Nov 24.
6
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.AGA 临床实践更新：非酒精性脂肪性肝病患者肝细胞癌的筛查和监测：专家综述。
Gastroenterology. 2020 May;158(6):1822-1830. doi: 10.1053/j.gastro.2019.12.053. Epub 2020 Jan 30.
7
Trends in Binge and Heavy Drinking among Adults in the United States, 2011-2017.2011 - 2017年美国成年人暴饮暴食及酗酒趋势
Subst Use Misuse. 2020;55(6):990-997. doi: 10.1080/10826084.2020.1717538. Epub 2020 Jan 30.
8
Review article: the prevention of hepatitis B-related hepatocellular carcinoma.综述文章：乙型肝炎相关肝细胞癌的预防。
Aliment Pharmacol Ther. 2018 Jul;48(1):5-14. doi: 10.1111/apt.14683. Epub 2018 May 3.
9
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.2000年至2012年美国50个州肝细胞癌的发病率
Gastroenterology. 2017 Mar;152(4):812-820.e5. doi: 10.1053/j.gastro.2016.11.020. Epub 2016 Nov 23.
10
Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030.美国肝细胞癌发病率至2030年的预测前景
J Clin Oncol. 2016 May 20;34(15):1787-94. doi: 10.1200/JCO.2015.64.7412. Epub 2016 Apr 4.

Editorial: Steatotic Liver Diseases Emerge as Rapidly Growing Drivers of Primary Liver Cancer in the United States.

作者信息

Torosian Kelly, Ajmera Veeral

机构信息

Division of Gastroenterology and Hepatology, University of California San Diego, La Jolla, California, USA.

MASLD Research Center, Division of Gastroenterology, University of California San Diego, La Jolla, California, USA.

出版信息

Aliment Pharmacol Ther. 2025 Mar;61(6):1057-1058. doi: 10.1111/apt.18508. Epub 2025 Jan 23.

DOI:10.1111/apt.18508
PMID:39846145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11870794/
Abstract
摘要